Evidence map›Paper›PMID 32730258›Full record

ArticlePloS one2020

Magnitude and predictors of khat use among patients with tuberculosis in Southwest Ethiopia: A longitudinal study.

Matiwos Soboka, Omega Tolessa, Markos Tesfaye, Kristina Adorjan, Wolfgang Krahl, Elias Tesfaye, Yimenu Yitayih, Ralf Strobl, Eva Grill

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Magnitude and trends ofThe Pan African medical journal · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Toxicology reports · 2022
    Article
  8. Review
  9. Protein-Ligand Identification andInternational journal of toxicology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Matiwos SobokaDepartment of Psychiatry, Jimma University, Jimma, Ethiopia.ORCID 0000-0003-2820-0947
Omega TolessaDepartment of Nursing, Wolkite University, Wolkite, Ethiopia.
Markos TesfayeCenter for International Health, Ludwig Maximilian University, Munich, Germany.
Kristina AdorjanCenter for International Health, Ludwig Maximilian University, Munich, Germany.
Wolfgang KrahlCenter for International Health, Ludwig Maximilian University, Munich, Germany.
Elias TesfayeDepartment of Psychiatry, Jimma University, Jimma, Ethiopia.
Yimenu YitayihDepartment of Psychiatry, Jimma University, Jimma, Ethiopia.
Ralf StroblInstitute for Medical Information Processing, Biometrics and Epidemiology, LMU Munich, Munich, Germany.
Eva GrillCenter for International Health, Ludwig Maximilian University, Munich, Germany.
Jimma University · ETLudwig-Maximilians-Universität München · DELMU Klinikum · DESt. Paul's Hospital Millennium Medical College · ETWolkite University · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTuberculosis (TB) is a leading cause of morbidity and mortality in low and middle-income countries. Substance use negatively affects TB treatment outcomes. Our recent study has found that khat use predicted poorer adherence to anti-TB medications. However, there is scarce longitudinal study on predictors of khat use among outpatients with TB, and this study aimed at addressing this research gap.

methodsFrom October 2017 to October 2018, 268 outpatients with tuberculosis on DOTs were enrolled in a longitudinal study from 26 health institutions in Southwest Ethiopia. Structured questionnaires translated into local languages (Afaan Oromoo and Amharic) were used to assess khat use. Patients were followed for six months, and data were collected on three occasions during the follow-up. A generalized linear mixed model was used to identify the relation between khat use and predictors. Model fitness was checked using the Bayesian Information Criterion (BIC). Odds ratio (OR) and 95% CI were used to describe the strength of association between the outcome variable and predictors.

resultsThe overall prevalence of khat use at baseline and first follow up was 39.2% while it was 37.3% at second follow up. Of this, 77.1% and 96.2% of them believed that khat use reduces the side effects of anti-TB medications and symptoms of tuberculosis respectively. In the final model, being male (aOR = 7.0, p-value = 0.001), being government employee (aOR = 0.03, p-value≤0.001) and presence of alcohol use disorders (AUD) (aOR = 2.0, p-value≤0.001) predicted khat use among outpatients with tuberculosis.

conclusionA considerable proportion of patients with TB used khat throughout DOTs and wrongly perceived that it had health benefits. The finding implies that all patients diagnosed with TB should be screened for khat use, and a particular emphasis should be given to males and individuals with a history of alcohol use. Moreover, further studies are needed to assess patients' beliefs regarding the benefits of khat use so that interventions can be developed.

Indexed as

AdolescentAdultAgedAged, 80 and overCathaCross-Sectional StudiesEthiopiaFemaleHumansLongitudinal StudiesMaleMiddle AgedMycobacterium tuberculosisPrevalenceRisk FactorsSubstance-Related Disorders

Identifiers

PMID32730258
PMCPMC7392297
OpenAlexW3046466380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.